Keke Wang
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
-
- Blood Pressure and Hypertension Studies
- Cardiovascular Health and Disease Prevention
- Cardiovascular Function and Risk Factors
Papers in
-
- Blood Pressure and Hypertension Studies 15
- Cardiovascular Health and Disease Prevention 9
- Cardiovascular Function and Risk Factors 5
- Heart Rate Variability and Autonomic Control 4
-
- Chronic Kidney Disease and Diabetes 5
Keke Wang
68 papers receiving 887 citations
Peers
Comparison fields: 5 of 113
- Nephrology 74
- Cardiology and Cardiovascular Medicine 234
- Cancer Research 121
- Endocrinology, Diabetes and Metabolism 100
- Pathology and Forensic Medicine 78
Countries citing papers authored by Keke Wang
This map shows the geographic impact of Keke Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keke Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keke Wang more than expected).
Fields of papers citing papers by Keke Wang
This network shows the impact of papers produced by Keke Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keke Wang. The network helps show where Keke Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Keke Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 24 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 23 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 6 | |
| 17 | 2019 | 24 | |
| 18 | 2019 | 31 | |
| 19 | 2018 | 30 | |
| 20 | 2017 | 27 |
About Keke Wang
Keke Wang is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Health Informatics, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 77 papers that have together received 900 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (15 papers), Cardiovascular Health and Disease Prevention (9 papers), Cardiovascular Function and Risk Factors (5 papers), Chronic Kidney Disease and Diabetes (5 papers), Heart Rate Variability and Autonomic Control (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Sodium Intake and Health (3 papers) and Cardiac Imaging and Diagnostics (3 papers). The work is most often cited by research in Nephrology (74 citations), Cardiology and Cardiovascular Medicine (234 citations), Cancer Research (121 citations), Endocrinology, Diabetes and Metabolism (100 citations) and Pathology and Forensic Medicine (78 citations). Keke Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Jianjun Mu, Chao Chu, Qiong Ma, Yu Yan, Jiawen Hu, Wenling Zheng, Zigang Dong, Ann M. Bode, Chen Chen and Yue‐Yuan Liao. Their work appears in journals such as Journal of Clinical Hypertension, Frontiers in Cardiovascular Medicine, Scientific Reports, Frontiers in Cell and Developmental Biology and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.